Summation with Auren Hoffman
Martin Shkreli on prison, beating Bloomberg, and being hated
Sponsors in this episode
No sponsor reads found in this episode's notes.
Host-read ads that the notes don't mention can't be found this way.
Show notes
Martin Shkreli is the co-founder of DL Software, the parent company of Godel Terminal, a Bloomberg competitor for financial data. He previously founded the biotech companies Retrophin and Turing Pharmaceuticals and the hedge fund MSMB Capital Management.
In this episode of Summation, Martin and Auren discuss:
The structural reasons fintech is less competitive than other industries
How drug discovery actually works (and doing it from prison)
Why AI labs are now out-recruiting hedge funds
What Martin learned from being "the most hated man in America"
You can find Auren Hoffman on X at @auren and Martin Shkreli on X at @MartinShkreli
From the show's RSS feed.